In a 57‑year‑old man treated for acute otitis media with amoxicillin‑clavulanate who now has improved ear pain but persistent temple headache and lip tingling without facial weakness (history of Bell’s palsy), what is the appropriate next management?

Reassure and Continue Current Management

The temple headache and lip tingling are most likely referred pain from resolving otitis media or temporomandibular joint (TMJ) involvement rather than Bell's palsy, and since the ear pain is improving without facial weakness, you should continue the current Augmentin course and reassess at 48–72 hours from treatment initiation. 1

Why This Is Not Bell's Palsy or Herpes Zoster Oticus

• Absence of facial weakness on examination definitively rules out Bell's palsy, which requires facial nerve paresis or paralysis for diagnosis 2
• Herpes zoster oticus (Ramsay Hunt syndrome) presents with vesicles on the external ear canal, severe otalgia, and facial paralysis—none of which are present in this patient 2
• The improvement in ear pain indicates appropriate antibiotic response, making infectious complications like mastoiditis or intracranial extension unlikely 1

Understanding the Temple Headache and Tingling

• Temporomandibular joint (TMJ) syndrome is the most common cause of referred otalgia and commonly presents with pain radiating to the periauricular area, temple, or neck 2
• Patients with TMJ dysfunction are tender over the affected joint and may have associated crepitus; they often have a history of gum chewing, bruxism, or recent dental procedures 2
• Referred pain from the ear to the temple is common in otitis media because both share sensory innervation from cranial nerves V, VII, IX, and X 2
• The lip tingling may represent paresthesia from TMJ dysfunction or anxiety related to his prior Bell's palsy episode, especially given the absence of objective neurologic findings 2

Expected Timeline for Otitis Media Resolution

• Clinical improvement in acute otitis media typically occurs within 48–72 hours after initiating antibiotic therapy 3
• During the first 24 hours, symptoms can transiently worsen before beginning to improve 3
• Successful treatment is indicated by decreasing fever, reduced irritability, and better sleep patterns—all of which this patient demonstrates (headache no longer waking him at night) 3
• Middle-ear effusion persists in 60–70% of patients at 2 weeks, 40% at 1 month, and 10–25% at 3 months after successful treatment; this does not require antibiotic escalation 1, 3

Appropriate Next Steps

• Continue the prescribed Augmentin regimen and reassess clinical status at 48–72 hours from treatment initiation 3
• Focus monitoring on primary symptoms (ear pain, fever, overall well-being) rather than isolated temple headache or lip tingling 3
• Examine the TMJ bilaterally by palpating anterior to the tragus while the patient opens and closes the mouth; tenderness or crepitus confirms TMJ involvement 2
• Recommend ibuprofen or acetaminophen for ongoing temple pain, as analgesics provide symptomatic relief independent of antibiotic effect 1

When to Escalate Antibiotic Therapy

• Consider treatment failure only if severe symptoms persist or worsen after 48–72 hours of therapy, such as persistent high fever, worsening ear pain, or new otorrhea 1, 3
• If true treatment failure occurs, switch to intramuscular ceftriaxone 50 mg/kg once daily for 3 consecutive days (superior to single-dose regimen) 1
• Mild persistent symptoms such as isolated temple headache, in the context of overall improvement, do not require antibiotic escalation 3

Critical Pitfalls to Avoid

• Do not escalate antibiotics based solely on lingering non-specific symptoms when the primary infection (ear pain) is improving 3
• Do not diagnose Bell's palsy without objective facial weakness; paresthesias alone are insufficient 2
• Do not overlook TMJ dysfunction as a cause of temple pain and referred otalgia, especially in patients with dental history or bruxism 2
• Avoid premature assessment before 48–72 hours, as this is the expected window for antibiotic response 3